Andere Sprachen NexImmune, Inc.

Aktien

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 26.04.2024			% 5 Tage	% 1. Jan.
3.37 ^USD	-1.17%		-3.44%	+51.80%

16.04.	NexImmune, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
05.04.	NexImmune, Inc. kündigt Änderungen in der Geschäftsführung an	CI

North American Morning Briefing : Stock Futures -2-	17.04.
NexImmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16.04.
North American Morning Briefing : Traders Await -2-	10.04.
NexImmune, Inc. Announces CFO Changes	05.04.
NexImmune, Inc. Announces Executive Changes	05.04.
North American Morning Briefing : Powell Awaited -2-	03.04.
NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	02.02.
Bull Run 2024: Biopharma Healthcare Stocks Surge, Gaining Momentum: DYAI, ABVC, FWBI, VTAK, NEXI	08.01.
Top Premarket Decliners	04.01.
Top Premarket Decliners	04.12.
Neximmune : Failure to Satisfy Listing Rule - Form 8-K	01.12.
Wall Street Set to Open Lower Friday as Investors Await Economic Data, Powell Speech	01.12.
Top Premarket Gainers	01.12.
Investors Look Ahead to Powell Speech as US Futures Trend Lower Friday	01.12.
North American Morning Briefing : Stocks Futures -2-	20.11.
NexImmune, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	17.11.
Top Premarket Decliners	06.11.
Top Premarket Decliners	03.11.
NexImmune Extends Partnership With Yale, JDRF for Type 1 Diabetes	24.10.23
NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes	24.10.23

Keine Ergebnisse zu dieser Suche